Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients
PHASE4CompletedINTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
November 30, 2004
Study Completion Date
November 30, 2006
Conditions
Hepatitis B
Interventions
BIOLOGICAL
Engerix-B and Twinrix
Trial Locations (1)
Unknown
St. Joseph's Healthcare, Hamilton
All Listed Sponsors
lead
St. Joseph's Health Care London
OTHER
NCT00186836 - Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients | Biotech Hunter | Biotech Hunter